Rapid Molecular Identification of Pathogenic Yeasts by Pyrosequencing Analysis of 35 Nucleotides of Internal Transcribed Spacer 2
- 1 October 2010
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 48 (10) , 3648-3653
Abstract
Rapid identification of yeast species isolates from clinical samples is particularly important given their innately variable antifungal susceptibility profiles. Here, we have evaluated the utility of pyrosequencing analysis of a portion of the internal transcribed spacer 2 region (ITS2) for identification of pathogenic yeasts. A total of 477 clinical isolates encompassing 43 different fungal species were subjected to pyrosequencing analysis in a strictly blinded study. The molecular identifications produced by pyrosequencing were compared with those obtained using conventional biochemical tests (AUXACOLOR2) and following PCR amplification and sequencing of the D1-D2 portion of the nuclear 28S large rRNA gene. More than 98% (469/477) of isolates encompassing 40 of the 43 fungal species tested were correctly identified by pyrosequencing of only 35 bp of ITS2. Moreover, BLAST searches of the public synchronized databases with the ITS2 pyrosequencing signature sequences revealed that there was only minimal sequence redundancy in the ITS2 under analysis. In all cases, the pyrosequencing signature sequences were unique to the yeast species (or species complex) under investigation. Finally, when pyrosequencing was combined with the Whatman FTA paper technology for the rapid extraction of fungal genomic DNA, molecular identification could be accomplished within 6 h from the time of starting from pure cultures.Keywords
This publication has 29 references indexed in Scilit:
- Pyrosequencing Analysis of 20 Nucleotides of Internal Transcribed Spacer 2 Discriminates Candida parapsilosis , Candida metapsilosis , and Candida orthopsilosisJournal of Clinical Microbiology, 2009
- Evaluation of Pyrosequencing® technology for the identification of clinically relevant non-dematiaceous yeasts and related speciesEuropean Journal of Clinical Microbiology & Infectious Diseases, 2008
- Prevalence and Susceptibility Profile of Candida metapsilosis and Candida orthopsilosis : Results from Population-Based Surveillance of Candidemia in SpainAntimicrobial Agents and Chemotherapy, 2008
- Candida nivariensis , an Emerging Pathogenic Fungus with Multidrug Resistance to Antifungal AgentsJournal of Clinical Microbiology, 2008
- Molecular Identification of Unusual Pathogenic Yeast Isolates by Large Ribosomal Subunit Gene Sequencing: 2 Years of Experience at the United Kingdom Mycology Reference LaboratoryJournal of Clinical Microbiology, 2007
- Epidemiology of Invasive Candidiasis: a Persistent Public Health ProblemClinical Microbiology Reviews, 2007
- Candida orthopsilosis and Candida metapsilosis spp. nov. To Replace Candida parapsilosis Groups II and IIIJournal of Clinical Microbiology, 2005
- International surveillance of blood stream infections due to Candida species in the European SENTRY program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agentsDiagnostic Microbiology and Infectious Disease, 1999
- NOSOCOMIAL CANDIDAInfectious Disease Clinics of North America, 1997
- High prevalence of antifungal resistance in Candida spp. from patients with AIDSJournal of Antimicrobial Chemotherapy, 1994